Champions Oncology

$8.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.70%) As of 10:24 AM EDT today

Why Robinhood?

You can buy or sell CSBR and other stocks, options, and ETFs commission-free!

About CSBR

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. Read More It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ. The listed name for CSBR is Champions Oncology, Inc. Common Stock.

Employees
143
Headquarters
Hackensack, New Jersey
Founded
1985
Market Cap
113.25M
Price-Earnings Ratio
Dividend Yield
Average Volume
27.35K
High Today
$8.92
Low Today
$8.85
Open Price
$8.88
Volume
1.65K
52 Week High
$10.89
52 Week Low
$4.02

Collections

CSBR Earnings

-$0.14
-$0.08
-$0.02
$0.04
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Estimated
per share
Actual
Expected Dec 14, After Hours

You May Also Like